Yellow discoloration of the sclera in newborns - Causes, Treatment & When to See a Doctor

```html

What is Yellow Discoloration of the Sclera in Newborns?

Yellow discoloration of the sclera (the white part of the eye) in a newborn is medically referred to as neonatal scleral icterus. It is a visible sign that bilirubin—a yellow‑pigmented breakdown product of red blood cells—is accumulating in the blood and depositing in the tissues. While a mild yellow tint is common in the first few days of life, persistent or worsening discoloration can indicate an underlying problem that needs prompt evaluation.

In healthy newborns, bilirubin levels rise physiologically because the liver is still maturing and cannot process bilirubin efficiently. This “physiologic jaundice” usually appears after 24 hours, peaks around day 3‑5, and resolves by 1–2 weeks without causing long‑term harm. However, when the sclera turns yellow earlier, becomes darker, or is accompanied by other symptoms, clinicians must differentiate physiologic jaundice from pathologic conditions that may require treatment.

Understanding the causes, associated signs, and when to seek care helps parents and caregivers act quickly, reducing the risk of serious complications such as kernicterus (bilirubin‑induced brain injury).

Common Causes

Below are the most frequent reasons a newborn’s sclera may appear yellow. The list includes both benign and potentially serious conditions.

• Physiologic newborn jaundice – Normal rise in bilirubin due to immature liver function.
• Breast‑feeding jaundice – Inadequate intake in the first days leading to dehydration and reduced bilirubin excretion.
• Breast‑milk jaundice – A later‑onset (days 5‑14) increase in bilirubin related to substances in breast milk that inhibit bilirubin conjugation.
• Hemolytic disease of the newborn (HDN) – Maternal antibodies (often Rh or ABO) destroy fetal red cells, rapidly raising bilirubin.
• G6PD deficiency – An inherited enzyme defect that predisposes red cells to oxidative damage and hemolysis.
• Congenital infections (TORCH) – Toxoplasmosis, rubella, cytomegalovirus, herpes simplex, and others can cause liver dysfunction.
• Neonatal hepatitis or biliary atresia – Inflammation or obstruction of bile flow leads to conjugated (direct) hyperbilirubinemia.
• Sepsis – Systemic infection can impair liver function and increase bilirubin production.
• Metabolic disorders – Conditions such as hypothyroidism, galactosemia, or maple‑syrup urine disease may present with jaundice.
• Drug‑induced jaundice – Some medications given to the mother (e.g., sulfadoxine‑pyrimethamine) or infant can affect bilirubin metabolism.

Associated Symptoms

Yellow sclera often appears with other signs that help clinicians determine the cause and urgency.

• Generalized skin yellowness (jaundice) – may first be seen on the face, then spread to the chest, abdomen, and limbs.
• Lethargy or excessive sleepiness.
• Poor feeding or difficulty latching.
• Vomiting, especially if bile‑stained.
• Dark, “tea‑colored” urine and pale, clay‑colored stools (suggesting conjugated bilirubin buildup).
• Rapid weight loss or failure to regain birth weight.
• Fever, irritability, or a limp, weak cry – possible signs of infection or sepsis.
• Palpable liver or spleen enlargement.
• Hemolysis clues: bruising, pallor, rapid heart rate, or a positive direct Coombs test.

When to See a Doctor

While many newborns develop mild jaundice that resolves on its own, you should contact a pediatrician or seek urgent care if any of the following occur:

• The yellow color appears within the first 24 hours of life.
• The discoloration spreads to the abdomen or limbs or becomes darker after day 3.
• Your baby is sleeping excessively, difficult to arouse, or unusually irritable.
• Feeding problems persist – less than 8–10 feedings per day or poor weight gain.
• There is vomiting, especially green or brown material.
• You notice dark urine, pale stools, or a distended abdomen.
• There is a known risk factor such as maternal blood‑type incompatibility, a sibling with neonatal jaundice, or a family history of G6PD deficiency.
• The baby has a fever >38 °C (100.4 °F) or appears septic.

Early evaluation is especially important because treatment thresholds differ for unconjugated (indirect) versus conjugated (direct) bilirubin, and some conditions can progress rapidly.

Diagnosis

Doctors use a step‑wise approach to determine the cause and severity of scleral icterus.

1. Clinical Examination

• Assess degree of skin and scleral discoloration using a standardized color chart (e.g., the Kramer scale).
• Examine for hepatomegaly, splenomegaly, and signs of hemolysis.
• Check vital signs, hydration status, and neuro‑behavioral responsiveness.

2. Laboratory Tests

• Serum total bilirubin – Measured via a heel‑stick (transcutaneous bilirubinometer) or venous sample.
• Direct (conjugated) vs. indirect (unconjugated) bilirubin – Helps differentiate physiologic from pathologic jaundice.
• Complete blood count (CBC) with reticulocyte count – Detects anemia/hemolysis.
• Blood type and Coombs test – Identifies ABO/Rh incompatibility.
• G6PD screening when hemolysis is suspected.
• Liver function panel (AST, ALT, alkaline phosphatase, GGT) – Evaluates hepatic injury.
• Urinalysis and stool color test – Distinguish conjugated bilirubin excretion.
• Infection work‑up (blood cultures, CRP, viral PCR) if sepsis is a concern.

3. Imaging (if indicated)

• Abdominal ultrasound – Assesses biliary tree for atresia or obstruction.
• Chest X‑ray – May be performed when respiratory distress co‑exists.

4. Risk‑Stratification Tools

Many hospitals use the American Academy of Pediatrics (AAP) bilirubin nomograms to decide if phototherapy or exchange transfusion is needed based on age in hours and bilirubin level.

Treatment Options

Management depends on bilirubin level, age, underlying cause, and presence of risk factors.

Phototherapy

• First‑line for most cases of moderate to high unconjugated bilirubin.
• Blue‑light (≈460 nm) converts bilirubin into water‑soluble isomers that can be excreted without conjugation.
• Typically administered via overhead lamps or fiber‑optic blankets.
• Duration varies – often 12–24 hours, with bilirubin rechecked frequently.

Exchange Transfusion

• Reserved for severe hyperbilirubinemia (e.g., >20 mg/dL in term infants) or when bilirubin rises despite intensive phototherapy.
• Involves replacing the infant’s blood with donor blood to rapidly lower bilirubin and remove antibodies.
• Performed in a neonatal intensive‑care unit (NICU) by experienced staff.

Addressing Specific Causes

• Breast‑feeding jaundice – Increase frequency of feeds (8‑12 times/day), ensure proper latch, and consider supplementing with expressed breast milk or formula temporarily.
• Breast‑milk jaundice – Continue breastfeeding but may offer occasional formula supplementation; bilirubin often normalizes by 2‑3 weeks.
• Hemolytic disease – Treat with phototherapy, possible immunoglobulin (IVIG), and exchange transfusion if indicated.
• G6PD deficiency – Avoid oxidative stressors (certain foods, sulfa drugs) and treat hemolysis supportively.
• Infection/Sepsis – Initiate appropriate antibiotics and supportive care.
• Biliary atresia or neonatal hepatitis – Early referral to pediatric surgery; Kasai portoenterostomy may be considered before 8 weeks of age.
• Metabolic disorders – Specific dietary or pharmacologic therapy (e.g., thyroid hormone for hypothyroidism).

Home Care Measures

• Maintain adequate hydration – Offer feeding every 2‑3 hours.
• Expose baby to indirect sunlight for short periods (10‑15 minutes) if advised by a clinician; direct sunlight is not a substitute for medical treatment.
• Track weight daily; a loss >10 % of birth weight warrants evaluation.
• Keep a record of feeding times and urine/stool output (aim for ≥6 wet diapers/day).

Prevention Tips

While not all cases are avoidable, several strategies can reduce the risk or severity of neonatal scleral icterus.

• Ensure early and frequent breastfeeding – Initiate within the first hour after birth and continue every 2–3 hours.
• Monitor newborn weight loss; >7 % loss should prompt pediatric follow‑up.
• Screen for blood‑type incompatibility during prenatal care; administer Rh immunoglobulin when indicated.
• Test for G6PD deficiency in at‑risk populations (e.g., Mediterranean, African, Asian ancestry).
• Educate parents on the normal timeline of physiologic jaundice and warning signs that require a call to the pediatrician.
• Provide appropriate vitamin K and hepatitis B immunizations per schedule, as some infections can cause jaundice.
• Avoid excessive use of “home remedies” (e.g., herbal teas, excessive sunlight) without medical guidance.

Emergency Warning Signs

If any of the following develop, seek emergency medical care (ED or call 911) immediately:

• Sudden worsening of yellow color, especially if the sclera become deep orange‑yellow or the skin looks “chalky”.
• Persistent high‑pitched crying that does not calm with soothing.
• Severe lethargy – the infant cannot be awakened or does not respond to stimuli.
• Muscle rigidity, arching of the back, or seizures – possible signs of kernicterus.
• Feeding refusal leading to dehydration (dry mouth, sunken fontanelle, <10 % urine output).
• Temperature >38 °C (100.4 °F) or <35.5 °C (95.9 °F) in a newborn.
• Rapid breathing (>60 breaths per minute) or bluish discoloration of lips or fingertips.

References

• Mayo Clinic. Jaundice in newborns. Updated 2023.
• American Academy of Pediatrics. Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. 2022.
• Centers for Disease Control and Prevention. Neonatal Jaundice. 2023.
• National Institute of Diabetes and Digestive and Kidney Diseases. Jaundice in Newborns. 2022.
• World Health Organization. Jaundice Fact Sheet. 2021.
• Cleveland Clinic. Newborn Jaundice. 2024.

```